Last reviewed · How we verify

NCT03358667: DERMA

Increase of Peri-implant Soft Tissues With Screw or Membrane

Completed Last updated 26 March 2021
What this trial tests

trial testing augmentation peri-implant soft tissue in Alveolar Bone Loss in 84 participants. Completed in 25 March 2021.

Timeline
1 November 2017
Primary endpoint
31 October 2019
25 March 2021

Quick facts

Lead sponsorInternational Piezosurgery Academy
StatusCompleted
Study typeOBSERVATIONAL
Enrollment84
Start date1 November 2017
Primary completion31 October 2019
Estimated completion25 March 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

International Piezosurgery Academy

Who can join

19 and older, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this observational study is to evaluate the growth of peri-implant soft tissues using an heterologous dermal membrane graft (group A) or a 2 mm healing screw used as a vertical support of the limbs (group B) positioned at the moment of surgical insertion of the implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other International Piezosurgery Academy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03358667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing